Orchestra BioMed Holdings (OBIO) Assets Average (2021 - 2026)

Orchestra BioMed Holdings (OBIO) has 6 years of Assets Average data on file, last reported at $107.8 million in Q1 2026.

• On a quarterly basis, Assets Average rose 59.38% year-over-year to $107.8 million in Q1 2026; TTM through Mar 2026 was $107.8 million, a 59.38% increase from a year earlier, with the FY2025 full-year figure at $95.5 million, up 11.46% from the prior year.
• Assets Average for Q1 2026 stood at $107.8 million, down from $109.8 million in the prior quarter.
• Over the last five years, Assets Average for OBIO reached as high as $161.7 million in Q1 2022 and fell as low as $50.9 million in Q2 2025.
• Historically, Assets Average has averaged $101.2 million across 5 years, with a median of $105.8 million in 2023.
• Across the five-year window, Assets Average slumped 49.27% in 2022 and jumped 59.38% in 2026, its largest moves.
• Year by year, Assets Average stood at $82.1 million in 2022, then climbed by 28.83% to $105.8 million in 2023, then decreased by 28.4% to $75.7 million in 2024, then jumped by 45.0% to $109.8 million in 2025, then declined by 1.89% to $107.8 million in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $107.8 million in Q1 2026, $109.8 million in Q4 2025, and $73.8 million in Q3 2025.